Regulations and Regulatory Advocacy
The United States Pharmacopeia (USP) today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards.
The United States Pharmacopeia (USP) recently finalized revisions to general chapter <797> (Pharmaceutical Compounding and Sterile Preparations). In addition, USP in 2016 finalized a new general chapter, <800> (Hazardous Drugs Handling in Healthcare Settings). Both general chapters have…
The AHA and five other hospital groups today filed a friend-of-the court brief urging the U.S. District Court for the Eastern District of Washington to prevent the Department of Homeland Security’s public charge rule from taking effect Oct. 15.
The AHA and five other hospital groups filed a friend-of-the court brief urging the U.S. District Court for the Eastern District of Washington to prevent the Department of Homeland Security’s public charge rule from taking effect Oct. 15.
The AHA today urged the Centers for Medicare & Medicaid Services to withdraw its proposal to rescind a 2015 rule that requires states to develop and submit access monitoring review plans for certain Medicaid services.
The rule would force millions of immigrants “to choose between accepting public services and accepting a green card … an impossible choice,” the brief states.
The AHA and five other hospital groups September 11, 2019, filed a friend-of-the court brief urging the U.S. District Court for the Northern District of California to prevent the Department of Homeland Security’s public charge rule from taking effect Oct. 15.
The edits were originally scheduled to take effect in July.
The Centers for Medicare & Medicaid Services today issued a final rule with comment period implementing additional program integrity requirements for health care providers and suppliers who participate in certain federal health insurance programs.
The Substance Abuse and Mental Health Services Administration today released a proposed rule that would amend federal regulations regarding disclosure of patient information for individuals seeking treatment for substance use disorders.